Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Endo Health Solutions Inc (ENDP)  
$0.00 0.00 (0.00%) as of 4:30 Tue 4/23


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 230,290,000
Market Cap: 138.17(K)
Last Volume: 11,847,187 Avg Vol: 11,814,278
52 Week Range: $0.0001 - $0.066
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 825
  Page 5 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mchugh Julie Chief Operating Officer   •       –      –    2013-03-08 4 A $0.00 $0 D/D 16,163 48,046     -
   Manogue Caroline B Exec. V.P., CLO & Secy   •       –      –    2013-03-08 4 A $0.00 $0 D/D 15,828 40,528     -
   Gergel Ivan EVP, Research & Development   •       –      –    2013-03-08 4 A $0.00 $0 D/D 15,952 42,709     -
   Farhat Camille President, AMS, Inc.   •       –      –    2013-03-08 4 A $0.00 $0 D/D 5,854 5,854     -
   Levin Alan G EVP, Chief Financial Officer   •       –      –    2013-03-08 4 A $0.00 $0 D/D 14,683 47,728     -
   Nash David Director   –       •      –    2013-03-05 4 B $30.80 $20,636 D/D 670 10,411 2.39     -
   Rudio Daniel Vice President, Controller   •       –      –    2013-02-28 4 S $30.91 $16,073 D/D (520) 526     -
   Rudio Daniel Vice President, Controller   •       –      –    2013-02-27 4 A $0.00 $0 D/D 2,727 2,727     -
   Rudio Daniel Vice President, Controller   •       –      –    2013-02-27 4 S $29.88 $23,008 D/D (770) 526     -
   Farhat Camille President, AMS, Inc.   •       –      –    2013-02-27 4 A $0.00 $0 D/D 2,927 2,927     -
   Manogue Caroline B Exec. V.P., CLO & Secy   •       –      –    2013-02-27 4 A $0.00 $0 D/D 7,914 7,914     -
   Gergel Ivan EVP, Research & Development   •       –      –    2013-02-27 4 A $0.00 $0 D/D 7,976 7,976     -
   Mchugh Julie Chief Operating Officer   •       –      –    2013-02-27 4 A $0.00 $0 D/D 8,081 8,081     -
   Levin Alan G EVP, Chief Financial Officer   •       –      –    2013-02-27 4 A $0.00 $0 D/D 7,342 7,342     -
   Holveck David President & CEO   •       •      –    2013-02-27 4 D $30.03 $589,909 D/D (19,644) 29,528     -
   Gergel Ivan EVP, Research & Development   •       –      –    2013-02-27 4 D $30.03 $215,255 D/D (7,168) 8,556     -
   Manogue Caroline B Exec. V.P., CLO & Secy   •       –      –    2013-02-27 4 D $30.03 $100,480 D/D (3,346) 7,452     -
   Mchugh Julie Chief Operating Officer   •       –      –    2013-02-26 4 D $28.09 $71,714 D/D (2,553) 2,700     -
   Levin Alan G EVP, Chief Financial Officer   •       –      –    2013-02-26 4 D $28.09 $95,309 D/D (3,393) 2,425     -
   Holveck David President & CEO   •       •      –    2013-02-26 4 D $28.09 $116,770 D/D (4,157) 9,052     -
   Gergel Ivan EVP, Research & Development   •       –      –    2013-02-26 4 D $28.09 $86,573 D/D (3,082) 1,820     -
   Manogue Caroline B Exec. V.P., CLO & Secy   •       –      –    2013-02-26 4 D $28.09 $55,281 D/D (1,968) 2,037     -
   Rudio Daniel Vice President, Controller   •       –      –    2013-02-21 4 S $28.10 $13,544 D/D (482) 526     -
   Hyatt Michael Director   –       •      –    2013-01-18 4 OE $11.05 $55,250 D/D 5,000 262,346     -
   Spengler William Director   –       •      –    2012-12-31 4 A $0.00 $0 D/D 1,649 32,390     -
  825 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us